Skip to content
Screener
Q4 '26Q3 '26Q2 '26Q1 '26Q4 '25
$396.75M+4.8%$383.54M+10.3%$373.91M+20.9%$363.89M+39.7%$378.7M+38.6%
$262.35M-2.4%$257.87M+6.0%$241.25M+16.3%$244.11M+38.0%$268.69M+44.4%
$134.4M+22.2%$125.68M+20.2%$132.66M+30.2%$119.78M+43.5%$110.01M+26.2%
33.9%+4.8pp32.8%+2.7pp35.5%+2.5pp32.9%+0.9pp29%-2.9pp
$86.24M+13.0%$81.02M+14.0%$82.33M+7.9%$68.52M+4.1%$76.29M+11.0%
$48.16M+42.8%$44.65M+33.2%$50.33M+97.1%$51.26M+190%$33.72M+83.1%
12.1%+3.2pp11.6%+2.0pp13.5%+5.2pp14.1%+7.3pp8.9%+2.2pp
-$10.18M-18.3%-$10.43M-11.5%-$11.76M-30.7%-$12.06M-57.8%-$8.61M-81.7%
-$5.63M-347%-$1.91M-135%-$2.15M+81.7%-$2.93M-570%-$1.26M+82.7%
$32.34M+35.6%$32.31M+8.8%$36.43M+653%$36.27M+277%$23.85M+272%
$10.63M+60.5%$8.29M-5.9%$8.97M+442%$9.74M+268%$6.62M+17.1%
$21.71M+26.0%$24.02M+15.1%$27.46M+762%$26.53M+280%$17.22M+2,190%
5.5%+0.9pp6.3%+0.3pp7.3%+6.3pp7.3%+4.6pp4.5%+4.3pp
$0.53+23.3%$0.59+15.7%$0.67+738%$0.65+282%$0.43+2,050%
$61.5M+33.3%$57.1M+23.8%$63.22M+70.4%$64.09M+140%$46.13M+67.0%
15.5%+3.3pp14.9%+1.6pp16.9%+4.9pp17.6%+7.4pp12.2%+2.1pp
$48.16M+42.8%$44.65M+33.2%$50.33M+97.1%$51.26M+190%$33.72M+83.1%

FAQ

What is Phibro Animal Health Corporation's revenue?
Phibro Animal Health Corporation (PAHC) generated $1.5B in revenue over the trailing twelve months, up 17.1% year over year.
Is Phibro Animal Health Corporation profitable?
Phibro Animal Health Corporation reported $99.7M in net income over the trailing twelve months, a 6.6% net margin.
What are Phibro Animal Health Corporation's profit margins?
Gross margin is 33.8% and operating margin is 12.8%, with a 6.6% net margin.
What is Phibro Animal Health Corporation's earnings per share?
Phibro Animal Health Corporation's diluted EPS over the trailing twelve months is $2.44.
Where does Phibro Animal Health Corporation's income statement data come from?
Every line is extracted from Phibro Animal Health Corporation's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.